SFX by Ex Libris Inc.

Title:	Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis
Source:	Science [0036-8075] Robitaille, A M yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ben Sahra, I. "Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1." Science 339.6125 (2013): 1323-1328.
description	2.	Bar Peled, L. "SnapShot: mTORC1 Signaling at the Lysosomal Surface." Cell 151.6 (2012): 1390-13900.
description	3.	Thoreen, C. "A unifying model for mTORC1-mediated regulation of mRNA translation.(RESEARCH: LETTER)(Report)." Nature 484.7396 (2012): 109-.
description	4.	Shyh Chang, Jason g. "Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation." Science 339.6116 (2012): 222-226.
description	5.	Wrighton, Katharine H. "Cell signalling: mTOR targets its own inhibitor." Nature reviews. Molecular cell biology 12.12 (2011): 769-769.
description	6.	Bar Peled, L. "A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1." Science 340.6136 (2013): 1100-1106.
description	7.	Blenis, J. "Metabolic Stress Controls mTORC1 Lysosomal Localization and Dimerization by Regulating the TTT-RUVBL1/2 Complex." Molecular cell 49.1 (2012): 172-186.
description	8.	Birsoy, K. "Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson." Nature medicine 18.7 (2012): 1022-1023.
description	9.	Possemato, R. "Functional genomics reveal that the serine synthesis pathway is essential in breast cancer." Nature 476.7360 (2011): 346-50.
description	10.	Yecies, Jessica L. "Transcriptional control of cellular metabolism by mTOR signaling." Cancer research 71.8 (2011): 2815-2820.
description	11.	Kumar, S. "Anticancer drug 5-fluorouracil induces reproductive and developmental defects in Caenorhabditis elegans." Reproductive toxicology 29.4 (2010): 415-420.
description	12.	Inoki, K. "TSC 2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling." Nature cell biology 4.9 (2002): 648-57.
description	13.	Dowling. "<bold>mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPS</bold>." Science 328.5982 (2010): 1172-1176.
description	14.	Carayol, N. "Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells.(APPLIED BIOLOGICAL SCIENCES)(Author abstract)." Proceedings of the National Academy of Sciences of the United States of America 07.28 (2010): 12469-.
description	15.	Klein, Benjamin Y. "Oxytocin modulates mTORC1 pathway in the gut." Biochemical and biophysical research communications 432.3 (2013): 466-471.
description	16.	Park, Ji H. "Involvement of PI3K-AKT-mTOR pathway in protein kinase CKII inhibition-mediated senescence in human colon cancer cells." Biochemical and biophysical research communications 433.4 (2013): 420-5.
description	17.	Wrighton, Katharine H. "Cell signalling: Where the mTOR action is." Nature reviews. Molecular cell biology 14.4 (2013): 191-191.
description	18.	Choi, H. "Inhibition of S6K1 enhances glucose deprivation-induced cell death via downregulation of anti-apoptotic proteins in MCF-7 breast cancer cells." Biochemical and biophysical research communications 432.1 (2013): 123-128.
description	19.	Northcott, Paul A. "Medulloblastomics: the end of the beginning." Nature Reviews. Cancer 12.12 (2012): 818-834.
description	20.	McDonald, Lindsay T. "Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin." International journal of clinical and experimental pathology 5.9 (2012): 863-873.